Abbott has announced Bowling Green, Ohio, will be the location for its new $500+ million specialty and metabolic powder nutritional products manufacturing facility. The state-of-the-art plant will bring additional capacity to the U.S. supply of these formulas, some of which serve as the sole source of nutrition for people with extreme allergies to most food products and other dietary and metabolic conditions.
For the design and build, Abbott will be consulting with experts in food safety, quality, and good manufacturing practices. “We’re building this plant for additional capacity to produce these important specialty and metabolic formulas that families rely on,” says Robert B. Ford, chairman and chief executive officer of Abbott. “Abbott has long been part of Ohio, and we’re proud to become part of the local community in Bowling Green.”
 | PACK EXPO Southeast Debuts Spring 2025 in Atlanta |
Groundbreaking is projected to begin next year, with construction expected to be complete in 2026, subject to necessary approvals. Abbott expects to start commercial production of products at the site in 2027. The facility will create 450 permanent jobs in the northwest Ohio region.
“Abbott’s history in formula production goes all the way back to Columbus [Ohio] in the early 1900s, and we’re glad Abbott is advancing its future here in Ohio as they bring a cutting-edge facility to Bowling Green that will support job growth and improve the supply chain for critical formula products nationwide,” says Ohio Governor Mike DeWine. “The addition of this new facility will help to ensure that life-sustaining formulas are available and accessible when needed.”
After the opening of the Bowling Green facility, Abbott plans to continue operating its Sturgis, Mich., plant, which also produces specialty and metabolic powder formulas.
